BOVESPA:BIOM3Biotechs
Biomm Third Quarter 2023 Earnings: R$0.27 loss per share (vs R$0.34 loss in 3Q 2022)
Biomm ( BVMF:BIOM3 ) Third Quarter 2023 Results Key Financial Results Revenue: R$33.1m (up 7.8% from 3Q 2022). Net...
BOVESPA:BIOM3Biotechs
Biomm (BVMF:BIOM3) Is Making Moderate Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
BOVESPA:BLAU3Biotechs
Could The Market Be Wrong About Blau Farmacêutica S.A. (BVMF:BLAU3) Given Its Attractive Financial Prospects?
With its stock down 17% over the past three months, it is easy to disregard Blau Farmacêutica (BVMF:BLAU3). But if you...
BOVESPA:BIOM3Biotechs
Biomm (BVMF:BIOM3 shareholders incur further losses as stock declines 11% this week, taking three-year losses to 72%
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So take...
BOVESPA:BLAU3Biotechs
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates
The analysts covering Blau Farmacêutica S.A. ( BVMF:BLAU3 ) delivered a dose of negativity to shareholders today, by...
BOVESPA:BIOM3Biotechs
Positive Sentiment Still Eludes Biomm S.A. (BVMF:BIOM3) Following 26% Share Price Slump
To the annoyance of some shareholders, Biomm S.A. ( BVMF:BIOM3 ) shares are down a considerable 26% in the last month...
BOVESPA:BLAU3Biotechs
Blau Farmacêutica's (BVMF:BLAU3) one-year earnings growth trails the shareholder returns
If you want to compound wealth in the stock market, you can do so by buying an index fund. But one can do better than...